These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8661192)

  • 1. Beta3 integrin expression in melanoma predicts subsequent metastasis.
    Hieken TJ; Farolan M; Ronan SG; Shilkaitis A; Wild L; Das Gupta TK
    J Surg Res; 1996 Jun; 63(1):169-73. PubMed ID: 8661192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.
    Natali PG; Hamby CV; Felding-Habermann B; Liang B; Nicotra MR; Di Filippo F; Giannarelli D; Temponi M; Ferrone S
    Cancer Res; 1997 Apr; 57(8):1554-60. PubMed ID: 9108459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of beta1 integrin expression in metastatic melanoma.
    Vihinen P; Nikkola J; Vlaykova T; Hahka-Kemppinen M; Talve L; Heino J; Pyrhönen S
    Melanoma Res; 2000 Jun; 10(3):243-51. PubMed ID: 10890378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of human melanoma-associated antigen ME491 along the progression of melanoma pre-canceroses to invasive and metastatic melanomas.
    Kondoh M; Ueda M; Ichihashi M; Mishima Y
    Melanoma Res; 1993 Aug; 3(4):241-5. PubMed ID: 8219756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteonectin/SPARC induction by ectopic beta(3) integrin in human radial growth phase primary melanoma cells.
    Sturm RA; Satyamoorthy K; Meier F; Gardiner BB; Smit DJ; Vaidya B; Herlyn M
    Cancer Res; 2002 Jan; 62(1):226-32. PubMed ID: 11782382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic fibroblast growth factor-2/beta3 integrin expression profile: signature of local progression after chemoradiotherapy for patients with locally advanced non-small-cell lung cancer.
    Massabeau C; Rouquette I; Lauwers-Cances V; Mazières J; Bachaud JM; Armand JP; Delisle MB; Favre G; Toulas C; Cohen-Jonathan-Moyal E
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):696-702. PubMed ID: 19386436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.
    Scala S; Ottaiano A; Ascierto PA; Cavalli M; Simeone E; Giuliano P; Napolitano M; Franco R; Botti G; Castello G
    Clin Cancer Res; 2005 Mar; 11(5):1835-41. PubMed ID: 15756007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours.
    Schadendorf D; Gawlik C; Haney U; Ostmeier H; Suter L; Czarnetzki BM
    J Pathol; 1993 Aug; 170(4):429-34. PubMed ID: 8105045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular prognostic markers in intermediate-thickness cutaneous malignant melanoma.
    Hieken TJ; Ronan SG; Farolan M; Shilkaitis AL; Das Gupta TK
    Cancer; 1999 Jan; 85(2):375-82. PubMed ID: 10023705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-v-beta3 integrin expression in melanocytic nevi and cutaneous melanoma.
    Neto DS; Pantaleão L; de Sá BC; Landman G
    J Cutan Pathol; 2007 Nov; 34(11):851-6. PubMed ID: 17944725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma.
    Salti GI; Manougian T; Farolan M; Shilkaitis A; Majumdar D; Das Gupta TK
    Cancer Res; 2000 Sep; 60(18):5012-6. PubMed ID: 11016620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel role for RGS1 in melanoma progression.
    Rangel J; Nosrati M; Leong SP; Haqq C; Miller JR; Sagebiel RW; Kashani-Sabet M
    Am J Surg Pathol; 2008 Aug; 32(8):1207-12. PubMed ID: 18580492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The loss of NM23 protein in malignant melanoma predicts lymphatic spread without affecting survival.
    Döme B; Somlai B; Tímár J
    Anticancer Res; 2000; 20(5C):3971-4. PubMed ID: 11268486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta 1 integrin expression: a marker of lymphatic metastases in cutaneous malignant melanoma.
    Hieken TJ; Ronan SG; Farolan M; Shilkaitis AL; Das Gupta TK
    Anticancer Res; 1996; 16(4B):2321-4. PubMed ID: 8694563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased gene expression levels of collagen receptor integrins are associated with decreased survival parameters in patients with advanced melanoma.
    Vuoristo M; Vihinen P; Vlaykova T; Nylund C; Heino J; Pyrhönen S
    Melanoma Res; 2007 Aug; 17(4):215-23. PubMed ID: 17625451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer.
    Gasparini G; Brooks PC; Biganzoli E; Vermeulen PB; Bonoldi E; Dirix LY; Ranieri G; Miceli R; Cheresh DA
    Clin Cancer Res; 1998 Nov; 4(11):2625-34. PubMed ID: 9829725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.